1. Home
  2. PNTG vs CRVS Comparison

PNTG vs CRVS Comparison

Compare PNTG & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

N/A

Current Price

$40.46

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$12.68

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PNTG
CRVS
Founded
2019
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
PNTG
CRVS
Price
$40.46
$12.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
6
Target Price
$37.00
$30.17
AVG Volume (30 Days)
201.0K
740.9K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
20.00
48.04
EPS
0.49
N/A
Revenue
$947,705,000.00
N/A
Revenue This Year
$24.72
N/A
Revenue Next Year
$7.61
N/A
P/E Ratio
$81.57
N/A
Revenue Growth
36.31
N/A
52 Week Low
$22.26
$5.70
52 Week High
$42.69
$26.95

Technical Indicators

Market Signals
Indicator
PNTG
CRVS
Relative Strength Index (RSI) 58.89 37.00
Support Level $38.50 $12.76
Resistance Level $40.55 $14.00
Average True Range (ATR) 1.20 0.58
MACD 0.24 -0.18
Stochastic Oscillator 91.34 18.59

Price Performance

Historical Comparison
PNTG
CRVS

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: